On September 28, 2012, Cytomedix, Inc. held its annual shareholder meeting at its executive offices in Gaithersburg, Maryland. The shareholders approved the following proposals:

Proposal 1 - Election of Directors. The shareholders elected James S. Benson, Mark T. McLoughlin, C. Eric Winzer, Stephen N. Keith, Martin P. Rosendale, Richard S. Kent, Lyle Hohnke, Joseph Del Guercio and David E. Jorden as directors to hold office until the next annual meeting of shareholders and until their successors are duly elected. A summary of votes cast follows below:

Name                Votes For  % For  Withheld*

James S. Benson     45,933,002 99.69% 144,590
Richard S. Kent     45,950,502 99.72% 127,090
Martin P. Rosendale 45,950,502 99.72% 127,090
Mark T. McLoughlin  45,937,902 99.70% 139,690
Stephen N. Keith    45,937,902 99.70% 139,690
Lyle Hohnke         45,806,163 99.41% 271,429
David E. Jorden     45,089,502 97.86% 988,090
C. Eric Winzer      45,934,502 99.69% 143,090
Joseph Del Guercio  44,518,690 96.62% 1,558,902

* Proxies received were voted, unless authority was withheld, in favor of the election of the nominees.

Proposal 2 - Ratification of Auditors. Shareholders also voted to ratify the appointment of Stegman & Company as the Company's independent registered accountant for the fiscal year ending December 31, 2012 with 70,597,654 shares voting for and 82,810 shares voting against the Proposal.